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Chronic diseases are rising in incidence and prevalence because of increases in life expectancy in many parts
of the world coupled with advances in medicine which manage disease progression, rather than curing and
alleviating the causes. Cataract is one such chronic condition. Identifying a therapeutic intervention that is
successful in reversing or preventing cataracts may have applications for other chronic diseases of protein
misfolding, such as diabetes and Alzheimer's disease as these have similar causation factors, notably
oxidative stress and/or glycation. Cerium oxide nanoparticles (nanoceria) which have antioxidant,
radioprotective and enzyme-mimetic properties have the potential to lead to an eﬀective non-surgical
treatment. However, nanoceria stability in physiological media is poor thus hindering their eﬀective use in
biomedical applications. Here we report a highly eﬃcient one-pot synthesis of nanoceria (2–5 nm) coated
with ethylene glycol, that is colloidally stable in physiological media and exhibits multiwavelength
photoluminescence. The formulation, up to concentrations of 200 mg ml1, was not toxic to human lens
epithelial cells and had no adverse eﬀect on the cellular morphology or proliferation rate. More
signiﬁcantly, these nanoceria showed protective eﬀects against oxidative stress induced by hydrogen
peroxide in lens epithelial cells. Electron microscopy studies show the internalization and cytoplasmic
localization of the nanoceria was found to be largely in the perinuclear region.Introduction
Amajor cause of chronic diseases that are exacerbated by ageing
are changes in protein structure that lead to malfunction of
tissues, organs and, ultimately, the organism. These are
conditions such as diabetes, Alzheimer's disease and cata-
racts.1,2 The latter can occur as solely ocular, or as a secondary
manifestation of a systemic condition.3 This presents the
opportunity of using cataracts as a model for investigating the
causal factors of visual impairment and to gain insight into
causal factors that underpin systemic protein-based diseases.
Cataract is an opacication of the eye lens that prevents light
from reaching the retina by either scattering or absorbing
traversing rays. It is the leading cause of blindness worldwide
with over 24 million cases in the United States reported in 2010
which is expected to double by 2050.4 Cataracts is a multifacto-
rial disease with oxidative stress considered to be one of the
major factors contributing to its development.3,5–9 The human
lens possesses natural defence mechanisms against reactive
oxygen species (ROS) including the presence of reduced gluta-
thione and antioxidant enzymes such as superoxide dismutasengham Trent University, Clion Lane,
.pierscionek@ntu.ac.uk
tion (ESI) available. See DOI:
5and catalase.8 With ageing, such defences weaken, rendering
the cells prone to oxidative insult that can lead to post-
translational modications and aggregation of lens proteins
(crystallins) eventually causing cataracts.3,8,9 Human lens
epithelial cells (HLECs) are the stem cells of the lens that
diﬀerentiate into bre cells forming the lens body. Oxidative
stress induced damage to the lens epithelial cells would result
in faulty protein synthesis and aggregation that eventually
would cause lens opacity.10 As such the use of HLECs as an in
vitro model has become important to draw conclusions on
cataracts progression. Currently, surgical extraction of the
cataractous lenses and replacement by intraocular implants is
the only approved treatment. This comes with limitations such
as accessibility in the developing world and the associated
perioperative and postoperative complications.11 Additionally,
to date there is no single implant model that can replicate the
image quality and the capacity to alter focus of the biological
lens.12 The annual cost associated with cataracts surgeries in the
US is estimated to be around $6.8 billion. This is expected to
increase as the average population age increases.13 As such,
there is a growing interest in developing a therapeutic means of
reversing, or at least halting, the progression of cataracts.
Cerium oxide is a rare earth metal oxide with multiple
applications in diverse products such as solar cells,14 oxygen
sensors,15 catalysis,16 UV lters,17 and polishing.18 Cerium oxide
(CeO2) nanoparticles or “nanoceria”, have shown potential forThis journal is © The Royal Society of Chemistry 2019
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View Article Onlinethe treatment and prevention of various disorders including
cancers,19 inammatory diseases,20 neurodegenerative disor-
ders,21 retinopathy,22 and cardiovascular dysfunctions.23 The
therapeutic eﬀects of nanoceria are attributed to their antioxi-
dant properties and their ability to eliminate ROS,24 and are
therefore promising candidates for treatment of cataracts and
associated systemic conditions. The antioxidant attributes of
nanoceria originate from the presence of crystal defects and
their associated oxygen vacancies allowing cerium atoms to co-
exist in and transition between trivalent and tetravalent states
(Ce3+ and Ce4+), a transition that is dependent on the ambient
environment.25,26 This antioxidant mechanism is distinct from
other molecular antioxidants for two main reasons. First, CeO2
can deactivate free radicals without being transformed into
a free radical itself. Secondly, the particles can recycle them-
selves in an ambient environment regenerating their antioxi-
dant properties in the process.25,27 Importantly, nanoceria have
manifested the ability to mimic the activity of key enzymatic
antioxidants, such as that of superoxide dismutase (SOD) by
reducing superoxide (O2
) to H2O2 as cerium transitions from
Ce3+ to Ce4+,28 and the subsequent oxidization of H2O2 into
innocuous oxygen as cerium reverts to its (III) oxidation
state.29,30 Nanoceria have previously been found to prevent
retinal degeneration in rats,31 and preliminary genotoxicity
studies have shown that negatively charged nanoceria do not
induce DNA damage in HLECs.32
Despite the therapeutic potential nanoceria hold, their poor
stability in physiological media is still challenging. Nanoceria
are highly susceptible to aggregation and subsequent sedi-
mentation in biological media.33 The aggregation is believed to
be caused by the presence of surface defects that increase with
particle size reduction.19 A formulation with poor colloidal
stability results in the sedimentation of the nanoparticles in
physiological media, consequently leading to the exposure of
cellular monolayers to a higher concentration than the stated
bulk concentration, and so compromising the reliability of in
vitro experiments.34 Eﬃcient dispersion of nanoparticles in
media is therefore of paramount importance to draw accurate
conclusions about the biological eﬀects of the employed
nanoparticle concentrations. Coating nanoceria with diﬀerent
materials improves colloidal stability.33 However, this is oen
accompanied by drastic changes in particle size, the use of
biologically incompatible coatings, organic synthesis routes, in
addition to the lack of suﬃcient colloidal stability data.33,35
In this study, we describe the successful formulation and
characterization of aqueously monodisperse nanoceria coated
with ethylene glycol and ethylene glycol acetates (EGCNPs)
using a simple and aqueous one pot precipitation reaction.
Cerium(III) acetate hydrate was employed as a precursor to
provide the reaction with acetate ligands that bind to ethylene
glycol forming a hybrid coat of ethylene glycol and its acetate
derivatives with high polarity. The formulation has superior
colloidal stability in aqueous solution and the nanoparticles
were readily dispersible from dried powder with mild agita-
tion. We have demonstrated that EGCNPs are safe in HLECs at
the concentrations required to provide signicant in vitro
protection against oxidative stress. The work described hereThis journal is © The Royal Society of Chemistry 2019indicates potential for nanoceria to be an anti-cataractogenic
treatment.
Experimental
Synthesis of ethylene glycol-coated cerium oxide
nanoparticles (EGCNPs)
EGCNPs were formulated using the alkaline precipitation
method with modications.33,36 Briey, cerium(III) acetate
hydrate (20 mmol, 6.3 g, Sigma Aldrich), ethylene glycol (10 ml,
99.99%, Fisher Scientic), and HCl (0.2 ml, 1 M) were added to
distilled water (100 ml), and le to homogenize (15 min at 40
C). Ammonia solution (35%, Fischer Scientic) was then added
dropwise until the pH reached 9.6. The initial buﬀ coloured
precipitate turned dark purple aer stirring (ca. 10 min). The
reaction was le stirring for 2 hour and the colour changed to
yellow. The reaction mixture was diluted with ethanol (50 ml),
and the precipitate was then collected by centrifugation
(3000 rpm, 5min), washed several times with distilled water and
ethanol and le to dry in an oven at 60 C. Aer drying, the
precipitate was ground into ne powder and stored in an
airtight container. Europium-doped nanoceria (EuCNPs) were
synthesized as above by adding europium nitrate (99.99%,
Sigma Aldrich) to the reaction mixture with a Ce : Eu molar
ratio of 1 : 0.2.37
EGCNPs characterization
Transmission electron microscopy (JeoL-2010, Tokyo, Japan)
was used to determine the morphology and particle size. The
crystalline structure of nanoceria was conrmed by powder X-
ray diﬀraction (X'Pert PRO, PANalytical) and the crystallite
size was calculated by applying the Scherrer equation. The
colloidal stability and surface charge in diﬀerent media were
studied by dynamic light scattering (NanoPlus, Particulate
Systems). Excitation and emission spectra were recorded using
a spectrouorometer (Clariostar, BMG LABTECH). The compo-
sition of the coating was conrmed by thermogravimetric
analysis (TGA 4000, PerkinElmer) connected to a GC-MS system
(GC Clarus 580 – MS Clarus SQ 8 S, PerkinElmer). Detailed
experimental conditions are provided in the ESI.†
Cell culture
Human lens epithelial cells (HLECs) B3 (ATCC® CRL11421™)
were grown in Eagle's minimum essential media (EMEM)
(ATCC® 30–2003) supplemented with foetal bovine serum
(20%, Scientic Lab Supplies), penicillin (100 IU ml1) and
streptomycin (0.1 mg ml1). Cells were incubated at 37 C and
5% CO2 in a humidied environment. All experiments were
conducted on cells in the logarithmic growth phase.
Live cell imaging and cell membrane integrity
The eﬀect of diﬀerent EGCNPs concentrations on the cytotox-
icity, proliferation and morphological features of HLECs was
observed using real-time live cell analysis. Cells were seeded in
6-well plates at a seeding density of 1  105 cells per well in
completed growth media (5 ml) and immediately treated withRSC Adv., 2019, 9, 16596–16605 | 16597
Fig. 1 Transmission electron microscopic (TEM) images of nanoceria
showing (a) ethylene glycol-coated nanoceria (EGCNPs) at 20k and (b)
EGNCPs at 100k magniﬁcation; both images show that particles are
relatively uniform in size and well separated with polygonal
morphology, (c) non-coated nanoceria (at 100k magniﬁcation) that
exhibit signiﬁcant clustering and polydispersity.
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View Article Onlinediﬀerent concentrations of EGCNPs (0, 50, 100, 200, 400 mg
ml1). This was conducted in the presence of Incucyte Cytotox
red for counting dead cells (250 nM, Essen Bioscience),
a cyanine nucleic acid dye that only permeates cells with
compromised cell membranes. Three elds of view were imaged
in each well, with a 10 objective every three hours over four
days using the Incucyte S3 Live Cell Analysis System (Essen
BioScience) tted inside an incubator. Conuence percentages
and cytotoxicity levels were calculated using the integrated
Incucyte S3 soware.
Cell viability of human lens epithelial cell line aer EGCNPS
exposure (MTT assay)
HLECs were seeded in 96-well plates with a seeding density of
5000 cells per well in 200 ml growth media. The cells were le to
recover from handling for 24 hours before treatment. Media
were then gently aspirated and replaced with fresh media con-
taining diﬀerent concentrations of EGCNPs. The tested EGCNPs
concentrations were 0, 100, 200, 400, 600, 800, 1000 mg ml1
with four wells per condition. Aer treatment durations (24 h or
48 h), 20 ml of MTT solution 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, 5 mg ml1 in PBS (Sigma
Aldrich) were added to each well to reach a nal concentration
of 0.5 mg ml1 and cells were incubated at 37 C for 2 hours.
Aer incubation, the MTT solution was gently aspirated and 200
ml dimethyl sulfoxide (DMSO) were added to each well and le
on a plate shaker for 10 minutes protected from light to solu-
bilize the formazan crystals. Absorbance readings were taken at
570 nm using a plate reader (Clariostar, BMG LABTECH).
Protective eﬀect against oxidative stress
The eﬀect of EGCNPs on oxidative stress levels in HLECs aer
H2O2 exposure was investigated using 20,70-dichlorodihydro-
uorescein diacetate (H2DCFDA) staining (D399, Thermo-
Fisher) according to supplier's instructions. Briey, cells were
seeded in 96-well plates as before, established for 24 h, then pre-
treated with diﬀerent EGCNPs concentration (0, 50 and 100 mg
ml1) for 24 h. Aer treatment period, media was removed, and
cells were washed with PBS and replaced with complete media
containing H2O2 (100 mM) for 1 h. Media was then removed,
washed once with PBS, and cells were incubated in H2DCFDA
solution (10 mM in PBS) for 30 min at 37 C. Cells were then
washed with PBS and 200 ml PBS was added to each well. DCF
uorescence intensity was measured using a plate reader
(TECAN innite 200 PRO) at excitation 495 nm/emission
529 nm.
Uptake and localization studies
Cells were grown to 70% conuence in full growth media on
cover slips in 6-well plates and then treated with 200 mg ml1
EGCNPs and incubated for one minute, 4 and 24 hours. Aer
each treatment duration, media were aspirated, and the cell
monolayers washed with serum free media followed by xation
in 4% paraformaldehyde in PBS buﬀer for 15 minutes. Cells
were then washed three times with PBS and dehydrated in
graded alcohol solutions (50%, 60%, 70%, 80%, 90% and 100%16598 | RSC Adv., 2019, 9, 16596–16605ethanol) for ve minutes each. The specimens were coated with
gold (5 nm) using a sputter coater (Q150R ES, Quorum) and
visualized under SEM (JEOL, JSM-7100f) with accelerating
voltage (10 kV) and probe current (10 mA). EDX spectra were
collected in at least ten diﬀerent cell compartments using Aztec
soware (Oxford Instruments). Details of confocal imaging of
EGCNPs and EuCNPs are available in ESI.†Statistical analysis
Each experiment was conducted at least three times (n $ 3).
Statistical analysis was carried out using GraphPad prism 7
soware. Where relevant, analysis of variance (one-way ANOVA)
followed by Dunnett's multiple comparisons test was used to
compare groups with statistical signicance set at p < 0.05.Results & discussion
EGCNPs characterization
Ethylene glycol has the ability to complex with Ce3+ ions,
making the reaction homogenous for the ensuing ammonia
precipitation step.33,38 Coating nanoceria with ethylene glycol
starting from a nitrate was previously reported to produce
relatively large particle sizes (>10 nm) and signicant poly-
dispersity due to aggregation in both water and cell media that
adversely impact biomedical applications.33 The ability to
produce water dispersible ultra-small (<5 nm) nanoceria is
desirable as size reduction increases ROS deactivation capacity
and regenerative properties29,39 and provides better penetration
into the cells than larger sized particles.40
Electron microscopic images (Fig. 1a and b) show the
nanoparticles to be crystalline with core sizes ranging from 2–
5 nm and an average size of 4.0 nm  0.8 nm. The images show
mosaic-like patterns of monodisperse and well-separated
nanoparticles. This is caused by the presence of ethylene
glycol which appears as transparent coronae in the TEM image
because of its low electron density compared to electron-rich
cerium oxide cores. Non-coated nanoceria exhibited larger
particle sizes (7–13 nm) with signicant aggregation and lack of
uniformity, highlighting the role of ethylene glycol coating in
stabilizing the synthesis (Fig. 1c). Powder XRD data conrmed
the cubic uorite crystalline structure of cerium(IV) oxide (CeO2)
which was in agreement with the structure reported in theThis journal is © The Royal Society of Chemistry 2019
Table 1 Particle size, polydispersity index and zeta potential
measurements of EGCNPs in diﬀerent physiological media (pH ¼ 7, 25
C)
Media Z-average (nm) PDI Zeta (mV)
(1) Distilled water 21.8  0.6 0.28 +44.1
(2) DMEM + FBS (20%) 128.7  9.2 0.17 9.7
(3) 0.9% saline 158.1  20.6 0.24 +14.0
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View Article Onlineliterature (JCPDS 75–0390). The characteristic 2q diﬀraction
peaks at 28.4, 33.3, 47.3, 56.12 correspond to the (111), (200),
(220), and (311) planes respectively, and are annotated on the
diﬀractogram (Fig S1a, ESI†). The peaks were signicantly
broader than non-coated nanoceria which is indicative of
smaller crystallite size.28 The crystallite size, calculated by
applying the Scherrer equation on (111) diﬀraction peak, was
3.5 nm. This is close to the average particle size calculated from
TEM images (4 nm).
The nature of the surface coating is shown in Fig. 2. Two
main regions of weight loss were observed. The initial weight
loss (10%) detected at 150 C was attributed to loss of residual
water and the outermost layer of the coating, while the second
weight loss (20%) indicated full decomposition of the coating
from 200–700 C. Mass spectroscopic data revealed that the
coating was a mixture of three compounds; ethylene glycol,
ethylene glycol monoacetate and ethylene glycol diacetate. The
additional carbonyl groups conferred by the acetate ligands on
the surface of the nanoparticles play an important role in the
aqueous stability of nanoceria through hydrogen bonding with
water molecules. Additionally, longer surface ligands are
generally associated with enhanced stability of the nano-
particles through the steric hindrance eﬀect.41,42
The presence of ethylene glycol surface coating was
conrmed not to interfere with the antioxidant and auto-
regenerative properties of nanoceria by testing EGCNPs reac-
tivity with H2O2. Transitions between Ce
3+ and Ce4+ were
marked by colour change of EGCNPs solution and a corre-
sponding shi in UV absorbance spectra (Fig S5, ESI†).25,27
FTIR spectra (Fig S1b, ESI†) conrmed the structure of
EGCNPs and this concurs with ndings reported in the litera-
ture.43 The presence of ethylene glycol coating was indicated by
the presence of two characteristic peaks corresponding to
methylene (CH2) stretching at 2950 and 2850 cm
1 and a very
broad peak at 3400 cm1 corresponding to (O–H) stretching.33
The (O–H) stretching band was signicantly prominent
compared to a non-coated formulation indicating that the band
pertains to additional (OH) groups from ethylene glycol andFig. 2 Thermogravimetric analysis (TGA) of EGCNPs showing two main
chromatography and analysed by mass spectrometry. The arrow indica
peaks at 2.1, 3.1 and 4.5 min correspond to ethylene glycol, ethylene
spectra are available in ESI†).
This journal is © The Royal Society of Chemistry 2019does not primarily arise from moisture adsorption on the
surface.44 The UV-vis spectrum for EGCNPs aqueous dispersion
showed a strong absorption peak at <299 nm (Fig. S1c, ESI†)
signifying the presence of Ce3+ the surface of the nanoparticles.
Ce3+ is known to absorb light between 230–260 nm while Ce4+
absorbs light in the region of 300–400 nm.19 A typical nanoceria
crystal contains cerium predominantly in its oxidized state
(Ce4+). As the crystal size decreases, surface defects associated
with oxygen vacancies arise, increasing Ce3+ at the surface. The
Ce4+/Ce3+ ratio is critical in determining the mechanism by
which nanoceria scavenge for ROS.29 The elemental composi-
tion of EGCNPs was conrmed by energy dispersive X-ray
spectroscopy (EDX) (Fig. S1d, ESI†).Colloidal stability and sterilization
The intensity weighted mean hydrodynamic diameter (Z-
average), polydispersity index (PDI) and zeta potential of
EGCNPs are summarized in Table 1.
In all tested media, EGCNPs showed unimodal distribution
of mean hydrodynamic diameters. The hydrodynamic diameter
was the smallest in water (21.86 nm) and increased signicantly
in other media while maintaining monodispersity. This was
demonstrated by small PDI values (Table 1). The increase in
hydrodynamic diameter in serum-containing DMEM can be
attributed to the adsorption of a thin layer of serum proteins on
the surface of particles forming a corona that contributes to its
overall measured hydrodynamic diameter.45,46 The association
of surface proteins was reected in the surface charge of theweight loss regions. The decomposed coating was separated by gas
tes the time at which GC-MS analysis was triggered. Chromatogram
glycol monoacetate and ethylene glycol diacetate respectively (mass
RSC Adv., 2019, 9, 16596–16605 | 16599
Fig. 3 Colloidal stability of ethylene glycol-coated nanoceria
(EGCNPs) and non-coated nanoceria kept in water at room temper-
ature for a week. Concentration of nanoceria in the supernatant was
determined at one-day intervals spectrophotometrically at 300 nm.
RSC Advances Paper
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
8 
M
ay
 2
01
9.
 D
ow
nl
oa
de
d 
on
 5
/2
9/
20
19
 1
:4
0:
29
 P
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinenanoceria and its inversion to a negative value.47 Serum proteins
are negatively charged at physiological pH and hence their
accumulation on the surface alters the nanoparticle zeta
potential.48 In saline solution, the increase in hydrodynamicFig. 4 (a) Emission spectra of EGCNPs suspended in water showing peak
and 513 nm respectively, (b) corresponding excitation spectra with dete
strong blue to violet emission when excited with UV excitation source (3
light excitation.
16600 | RSC Adv., 2019, 9, 16596–16605diameter was expected as high salt concentrations are known to
shield the electrical eld around nanoparticles reducing the
electrostatic repulsion and causing agglomeration.49 This is
clearly manifested in the decrease in positive charge in saline
solution compared to the value in water (Table 1). Despite that,
the nanoparticles remained well dispersed in all media with no
signs of precipitation. The small particle size in water permitted
sterilization by ltration through 0.22 mm lters with minimal
loss of the nanoparticles (less than 6% loss) as conrmed
spectrophotometrically at 300 nm. The amount of EGCNPs lost
aer sterilization was found to decrease as the volume of
ltered solution passing through the same lter increased,
suggesting that the loss was due to adsorption on the lter
surface.
When le to precipitate over one week at room temperature
in water, EGCNPs showed a slight loss in the supernatant
concentration (6%) over the testing duration. This level of
stability was superior to their non-coated counterparts for
which a signicant loss in supernatant concentration (>35%)
was observed aer 24 h, highlighting the role of ethylene glycol
coating in stabilizing the dispersion (Fig. 3). The previously
reported synthesis of ethylene-glycol coated nanoparticles from
a nitrate precursor resulted in hydrodynamic diameters of
222 nm and 206 nm in water and RPMI + FBS (10%) respectively,
and both exhibited signicant polydispersity with bimodal sizes at 440 nm, 533 nm and 632 nm when excited with 390 nm, 450 nm,
ction bandwidths set at 10 nm, (c) EGCNPs suspension demonstrating
80 nm), (d) EGCNPs powder showing broad green emission after blue
This journal is © The Royal Society of Chemistry 2019
Fig. 5 Confocal images of a cluster of EGCNPs powder upon 405 nm
excitation with emissions detected at (a) 450 nm, (b) 550 nm and (c)
630 nm.
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View Article Onlinedistribution.33 Moreover, the colloidal stability study of that
formulation showed 38% loss of nanoceria content in the
supernatant when a dispersion was le to precipitate for 7 days.
This could be attributed to better stability and monodispersity
of EGCNPs to the reaction initiation from an acetate precursor
(as opposed to a nitrate precursor) that reacted with ethylene
glycol and formed monoacetate and diacetate ethylene glycol
derivatives. These ligands were more stable because steric
hindrance prevented aggregation. Additionally, the acetate
derivatives provided the coating with carbonyl groups that can
form hydrogen bonding in aqueous solvents. To the best of our
knowledge, the EGCNPs described here are the simplest aque-
ously stable nanoceria with a well-dened colloidal stability that
can be formulated and stored in a dry powder form.Photoluminescence and optical properties
EGCNPs exhibited multi-coloured emissions that extend from
the UV to the long wavelength region of the visible spectrum.
Fig. 4a and b show the EGCNPs emissions in the short, medium
and long wavelength ranges of the visible spectrum when
excited with 390, 450 and 513 nm respectively. The short
wavelength emission was broad with the peak tail reaching
beyond 600 nm (Fig. 4a). Both excitation and emission spectra
have suﬃcient breadth, rendering the detection of nano-
particles highly tunable. In general, the uorescence is rela-
tively faint and requires strong laser power for excitation. Blue
and green emissions were detected in both dispersion and
powder forms when excited with the appropriate wavelengths
(Fig. 4c and d).Fig. 6 MTT cell viability assay in HLECs with diﬀerent EGCNPs concentra
after 48 hours of exposure. Error bars are represented as mean  SEM
control (p value < 0.05).
This journal is © The Royal Society of Chemistry 2019When examined with laser scanning confocal microscopy,
emissions from EGCNPs powder were detected across the
visible spectrum using a single excitation wavelength of 405 nm
as shown in Fig. 5. This agrees with the broad emission spectra
of EGCNPs aer UV excitation (Fig. 4a).
The photoluminescent behaviour of nanoceria has been re-
ported in the literature, but ndings are not consistent.
Krishnan et al. reported multi-coloured uorescence of orga-
nophilic 2–3 nm oleic acid-coated CeO2 nanodots (OACNPs)
fabricated by solvothermal decomposition.50 OACNPs dispersed
in toluene exhibited blue (lex ¼ 350), green (lex ¼ 405) and red
emissions (lex ¼ 532).50 These unique uorescent properties
were attributed to a large number of crystal defects associated
with nanoparticle size (2 nm) with a higher Ce3+ to Ce4+ ratio.50
A CeO2 lm deposited (80 nm) on a silica substrate was reported
to have violet to blue luminescence at 380 nm.51 Nanoceria (2
nm), coated with a double layer of oleic acid prepared by
thermal decomposition, were reported to have a broad spec-
trum with maximum emission at 515 nm with 400 nm excita-
tion.52 To our knowledge, no other study has found that
nanoceria prepared by an aqueous precipitation method can
exhibit such multi-coloured photoluminescence, nor that
nanoceria can be detected using a uorescent microscope in all
visible regions of light spectrum using a single excitation
wavelength.Cell viability, proliferation and morphology
The impact of diﬀerent concentrations of EGCNPs (0 to 1000 mg
ml1) on cultured HLECs, aer 24 h and 48 h exposure in
culture media is shown in Fig. 6. EGCNPs with concentrations
up to 200 mg ml1 did not have any signicant eﬀect on cell
viability, when compared to control cells at the two tested time
points (p value < 0.05). However, the 24 h exposure to concen-
trations of 400 mg ml1 or higher resulted in a statistically
signicant decrease in viability ranging from 27% (at 400 mg
ml1) to 40% (1000 mg ml1). The genotoxicity of negatively
charged nanoceria have been previously investigated on HLECs
– the durations were longer than in this study but the concen-
trations were not as high.10,32 Previous studies have shown no
cytotoxicity of negatively charged ethylene glycol-coatedtions. Concentrations up to 200 mg ml1 are well tolerated by the cells
. Asterisks denote statistically signiﬁcant diﬀerence from the negative
RSC Adv., 2019, 9, 16596–16605 | 16601
Fig. 8 Live cell analysis showing cytotoxicity,morphology and proliferation in
EGCNPs concentration and allowed to proliferate in presence of Cytotox R
rescence. Images were taken using Incucyte S3 live cell imaging system (10
with 200 mgml1 EGCNPs, (d) treatedwith 400 mgml1 EGCNPs. Error bars ar
between treated and control cells at each time point (one-way ANOVA) ind
Fig. 7 Eﬀect of diﬀerent EGCNPs concentrations on HLECs prolifer-
ation. Cells were imaged in 6-well plates at an interval of 3 hours for 3
days while growing in full growth media using IncuCyte S3 live cell
imaging system. Four diﬀerent spots were imaged in each well. %
Conﬂuence was analysed by the integrated IncuCyte software and
plotted against elapsed time in hours. Conﬂuence at 0 h indicates the
cell density at the point of seeding. All cells reached full conﬂuence by
72 h. Small variations in early stage of growth arise from statistically
insigniﬁcant variations in the four areas imaged in each well. A time
lapse movie of cell growth over 4 days is available in the ESI.†
16602 | RSC Adv., 2019, 9, 16596–16605
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View Article Onlinenanoceria on Jurkat human T-lymphocytes aer three days of
exposure.33 However, no uptake studies were conducted and
hence the lack of cytotoxicity might have been the result of
a lack of uptake of the nanoparticles. Poor or lack of internali-
zation of negatively charged nanoceria has been previously
found in two normal cell lines; embryonic kidney cells and H9c2
cardiac myocytes.53 The same study showed signicant cyto-
toxicity of positively charged nanoceria (1 mM, 172 mg ml1) on
the same cell lines aer 24 hour exposure.53 It is noteworthy that
the positive charges on the surface of nanomaterials promote
cellular adhesion and penetration owing to the ionic interac-
tions with negatively charged cell surfaces and hence their
cytotoxicity is generally expected to be more pronounced
compared to negatively charged nanomaterials.54,55 It is possible
that the adsorption of negatively charge coronae on the surface
of EGCNPs reduced their toxicity by mitigating cell membrane
damage normally associated with positive charged
nanoparticles.56
Fig. 7 shows the proliferation of HLECs incubated with
diﬀerent EGCNPs concentrations (0 to 400 mg ml1) for threeHLECs uponEGCNPs exposure up to 72 h. Cellswere treatedwith diﬀerent
ed dye (250 nM) that binds to the DNA of dead cells and gives red ﬂuo-
objective). (a) Control cells, (b) treatedwith 100 mgml1 EGCNPs, (c) treated
e displayed asmean SEM. No statistically signiﬁcant diﬀerencewas found
icating that EGCNPs are not cytotoxic at these exposure conditions.
This journal is © The Royal Society of Chemistry 2019
Fig. 9 EGCNPs protect against H2O2-induced oxidative stress in
human lens epithelial cells (H2DCFDA assay). Cells were pre-treated
with EGCNPs for 24 h, and then exposed to H2O2 (100 mM) for 1 h in
EGCNPs-free media. Oxidative stress levels were determined by
measuring DCF ﬂuorescence intensity using a plate reader. Asterisks
denote statistical signiﬁcance (n ¼ 3, p < 0.05, ANOVA followed by
Dunnett's test). Error bars are displayed as mean  SEM.
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View Article Onlinedays without media change. All cells with diﬀerent treatments
were able to reach 100% conuence following a similar growth
pattern to negative controls. This contrasted with results from
the MTT assay that showed a decrease in viability for cells
incubated with EGNCPs (400 mg ml1). The results of further
investigation with nucleic acid staining are shown in Fig. 8. No
cytotoxicity was observed for concentrations (50–400 mg ml1)
for exposure durations up to 72 h. This could be a result of the
400 mg ml1 concentration interfering with mitochondrial
activity which could in turn have aﬀected the MTT viability.57
Nonetheless, we conclude that EGCNPs concentrations, from 50
to 200 mg ml1 were safe and had no harmful eﬀect on theFig. 10 SEM images showing uptake and localization of EGCNPs in HLE
EGCNPs, (b) EGCNPs uptake and localization after 4 h incubation, (c) EG
detected at 4 h and 24 h time points with heavy localization around the
distinguished by brightness arising from atomic number contrast of ce
secondary and backscattered electrons. Contrast sensitive pseudocolo
localization as bright green. EDX spectra are available in the ESI.†
This journal is © The Royal Society of Chemistry 2019morphology, proliferation, and cell membrane integrity of the
HLECs aer 72 h exposure.Protective eﬀects of EGCNPs against ROS in lens cells
EGCNPs, with predetermined safe concentrations (50 and 100
mg ml1), were tested for their ability to protect HLECs from
oxidative damage induced by H2O2 using H2DCFDA probe. As
shown in Fig. 9, the tested EGCNPs concentrations exhibited
a signicant protective eﬀect compared to non-EGCNPs treated
cells demonstrated by the low uorescence levels in cells pre-
treated with EGCNPs. Both concentrations showed a similar
level of protection against H2O2-induced oxidative stress. Such
protective eﬀect shows that EGCNPs inside the HLECs can exert
catalase-like activity where excess H2O2 was deactivated.39
Moreover, cultured cells that were exposed to EGCNPs were able
to reach full conuence aer three days compared to the posi-
tive control in which cell proliferation was signicantly halted
supporting H2DCFDA assay ndings (Fig S6, ESI†).Uptake and localization of EGCNPs in human lens epithelial
cells
The cellular localization of nanoparticles plays an important
role in their overall toxicity and activity.58 Many factors impact
on the uptake of nanoparticles such as particle size, poly-
dispersity, zeta potential and surface coating.
Fig. 10 shows the uptake and localization of EGCNPs in
HLECs aer incubation for 4 h (Fig. 10b) and 24 h (Fig. 10c).
EGCNPs entered the cells at signicant levels for both tested
time points. The nanoparticles were heavily localized in the
cytoplasm, mainly in perinuclear regions (Fig. 10b and c).
Minimal amounts of nanoceria were detected in the nuclei as
conrmed by EDX spectra (Fig S4, ESI†).Cs at diﬀerent time points: (a) 1 min incubation showing no uptake of
CNPs uptake and localization after 24 h incubation. Strong uptake was
nuclei as detected by EDX. Areas with most nanoceria localization are
rium element (Ce atomic number ¼ 58) and hence it gives oﬀ more
ur was applied simultaneously to the images highlighting nanoceria
RSC Adv., 2019, 9, 16596–16605 | 16603
Fig. 11 Uptake and perinuclear localisation of EGCNPs and EuCNPs in
HLECs. (a) and (b) Confocal images showing cytoplasmic localisation
of EGCNPs in HLECs (excitation 488 nm/emission 530 nm), (c)
a confocalmicroscopy image showing localisation of nanoceria doped
with europium (EuCNPs). (d) SEM images showing cytoplasmic local-
isation of EuCNPs (green areas).
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View Article OnlineFor further validation of SEM-EDX uptake and localization,
confocal microscopy experiments were conducted. HLECs
exhibited strong autouorescence in the blue and green
regions. Even though the uorescence of EGCNPs is relatively
weak compared to cellular autouorescence, it can still be
tracked inside the cells by taking advantage of the lanthanides
ability to resist photobleaching.59 Fig. 11a and b conrm that
EGCNPs are predominantly localised in the cytoplasm, speci-
cally in the perinuclear regions. This concurs with SEM data.
The images show that some nanoparticles penetrate the
nucleus. Such minimal nuclear uptake is likely to have taken
place during mitosis where nuclear membrane breaks down.60
To our knowledge this the rst time unlabelled nanoceria have
been tracked inside the cells.
The EuCNPs exhibited typical strong red emission at 612 nm
under multiple excitation wavelengths from UV to end of green
region (ranging from 350–550 nm);61 particle size (5 nm) and
surface charge (+34.49 mV in water, 2.4 mV in media) were
similar to those of EGCNPs. Doping with Europium is preferred
over attachment of traditional uorescent dyes since the latter
involves surface modications that could aﬀect the behaviour of
the nanoparticle uptake.62 Characterization of EuCNPs is avail-
able in the ESI (Fig S2†). Aer 24 hour incubation with HLECs,
EuCNPs were found in the cytoplasm mainly in the perinuclear
region corroborating the previous ndings (Fig. 11c). EuCNPs
also showed a similar localization pattern to EGCNPs when
examined by SEM-EDX (Fig. 11b). It remains to be investigated
whether surface charge manipulationmay have an impact on the
uptake and localization of nanoceria in HLECs cells and its
relationship to cytotoxicity and protective behaviour.
Uptake studies show that EGCNPs preferentially reside in the
cytoplasm surrounding the nuclei. Such localisation resulted in
no cytotoxicity to HLECs and the nanoparticles showed
protection against oxidative stress.16604 | RSC Adv., 2019, 9, 16596–16605Conclusions
A nanoceria formulation coated with ethylene glycol and
ethylene glycol acetates (EGCNPs) was successfully formulated
using a simple precipitation reaction starting from cerium
acetate as the precursor. The formulation has superior aqueous
stability and monodispersity in diﬀerent physiological media
allowing for more reliable biological studies with no
sedimentation-induced variabilities. EGCNPs were found to be
heavily localised in the cytoplasm and provided protection in
human lens epithelial cells from H2O2-induced oxidative stress,
rendering these particles a potential candidate for an anti-
cataracts therapy. Future work is needed to elucidate the
mechanism and mode of action of nanoceria within the cellular
organelles and their regenerative antioxidant properties if these
are to be eﬀective for the treatment of cataracts.Conﬂicts of interest
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